KOSSAN RUBBER INDUSTRIES BHD

KLSE (MYR): KOSSAN (7153)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

2.36

Today's Change

0.00 (0.00%)

Day's Change

2.35 - 2.37

Trading Volume

135,900


19 people like this.

16,202 comment(s). Last comment by KimSua 18 hours ago

Hoot9e

239 posts

Posted by Hoot9e > 2020-12-11 16:25 | Report Abuse

manage to buy 5.32, then sell 5.4... dapat nasi ayam malam ini

NPRA1985

3,415 posts

Posted by NPRA1985 > 2020-12-11 16:29 | Report Abuse

I think institutions have already mostly withdrawn from glove counters and moved on the recovery theme counters leaving mostly retailers in the glove counters. Please correct me if am wrong...

Hoot9e

239 posts

Posted by Hoot9e > 2020-12-11 16:30 | Report Abuse

wa... turun lagi 5.35

calvintaneng

56,562 posts

Posted by calvintaneng > 2020-12-11 16:30 | Report Abuse

KOSSAN OVER SOLD

BUY NOW WHILE CHEAP AS WELL AS LUXCHEM

Hoot9e

239 posts

Posted by Hoot9e > 2020-12-11 16:32 | Report Abuse

ya... oversold .
monday will rebound

roshazli

153 posts

Posted by roshazli > 2020-12-11 16:34 | Report Abuse

Fact box: When and which Covid-19 vaccines are likely to be available in Asia

BEIJING/TOKYO/SEOUL/MANILA/TAIPEI/JAKARTA/DHAKA/HANOI (Dec 11): Trial data from Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc has shown their experimental vaccines are effective in preventing novel coronavirus infection.
While regulatory processes are underway, few Asian countries expect to receive significant amounts of the vaccines initially. Here are estimated distribution time lines, supply deals announced and clinical trials being held in the region.

Australia
The country has secured around 140 million doses: 53.8 million from AstraZeneca, 51 million from Novavax Inc, 10 million from Pfizer, and 25.5 million from distribution programme COVAX.
It expects delivery of 3.8 million doses of AstraZeneca's vaccine in January and February next year and plans to begin inoculations in March.

China
China has not announced supply deals with Western drugmakers, which instead have partnered with private companies in the country.AstraZeneca's vaccine may be approved in China by mid-2021 and its Chinese partner Shenzhen Kangtai Biological Products Co Ltd plans annual production capacity of at least 100 million doses by the end of this year.
For the Pfizer/BioNTech vaccine, a unit of Shanghai Fosun Pharmaceutical Group Co Ltd plans a Phase II trial.
Tibet Rhodiola Pharmaceutical Holding Co is bringing in Russian vaccine candidate Sputnik V and plans early and mid-stage trials in China.
China has also approved three vaccine candidates developed by Sinovac Biotech Ltd and state-owned China National Pharmaceutical Group (Sinopharm) for emergency use, and Sinopharm hopes its two candidates will get conditional approval for general use this year.

Japan
Japan has deals to buy 120 million doses from Pfizer/BioNTech in the first half of next year and 120 million from AstraZeneca - the first 30 million of which will be shipped by March 2021 - and 250 million from Novavax.
It is also in talks with Johnson & Johnson and has a deal with Shionogi & Co Ltd.
Experts said vaccine makers would need to conduct at least Phase I and II trials in Japan before seeking approval for use.

South Korea
The country has deals to buy 20 million doses each from AstraZeneca, Pfizer and Moderna and another 4 million doses from Johnson & Johnson's Janssen, enough to cover up to 34 million people.It will procure additional doses for 10 million people through COVAX.Inoculation is likely to start in the second quarter of next year to allow time to observe possible side effects.

India
The head of the Serum Institute of India, which makes the AstraZeneca vaccine, said on Nov. 23 the positive late-state trial result of the candidate will allow it to seek emergency use approval by year-end, before securing approval for full introduction by February or March.
India also expects a government-backed vaccine to be launched as early as February. It is also conducting a late-stage trial of Sputnik V.

Taiwan
Taiwan aims to secure around 15 million doses initially, both via the COVAX scheme and by direct purchases from manufacturers, and may buy an additional 15 million doses.
The government has said it hopes to begin vaccinations in the first quarter next year.

Malaysia
The Southeast Asian nation has agreed to buy 12.8 million doses of the Pfizer vaccine, becoming the first country in the region to announce a deal with the U.S. drugmaker after some expressed reservations over the need for the ultra-cold storage that the vaccine requires.
Pfizer will deliver the first batch of 1 million doses in the first quarter of next year.

The Philippines
The archipelago announced a deal on Nov. 27 for 2.6 million doses of the AstraZeneca vaccine and is discussing a possible 1 million more, covering about 1% of a population of 108 million people.It is also seeking 20 million to 50 million doses from Sinovac and is in talks with others, including Pfizer.Vaccine makers can seek approval from Philippine regulators even if no clinical trial is conducted in the country.

Indonesia
Southeast Asia's most populous country has secured 125.5 million doses from Sinovac, 30 million from Novavax, is in talks with AstraZeneca and Pfizer to buy 50 million doses each, and expects to get 16 million from COVAX.Indonesia is testing Sinovac's vaccine and preparing mass vaccination for medical staff and other frontline workers to start as soon as late January.

Vietnam
A government official said COVAX vaccines would cover only 20% of the population and the country is likely to have a chance to secure separate deals soon, as demand is very high.

Bangladesh
Bangladesh signed a deal with India's Serum Institute to buy 30 million doses of the AstraZeneca vaccine.It also expects to receive 68 million doses from global vaccine alliance GAVI at a subsidised rate, a senior health ministry official said.

kens88

698 posts

Posted by kens88 > 2020-12-11 16:53 | Report Abuse

No limit down, consider good

jolow

652 posts

Posted by jolow > 2020-12-11 17:23 | Report Abuse

worst is yet to come.
hopefully everyone can survive for next year

kens88

698 posts

Posted by kens88 > 2020-12-11 17:26 | Report Abuse

Yes. I believe price drop to rm 2

kens88

698 posts

Posted by kens88 > 2020-12-11 17:26 | Report Abuse

Hope kossan faster delist

Albukhary

3,042 posts

Posted by Albukhary > 2020-12-11 17:28 | Report Abuse

THANKS KOSSAN, I EAT VERY FULL TODAY.
THIS WEEKEND LET ME GO FIND SOME MONEY, HOPEFULLY NEXT WEEK CAN EAT AGAIN.

jolow

652 posts

Posted by jolow > 2020-12-11 17:30 | Report Abuse

downtrend confirm started.
better sell early.

Posted by Belisto Skrang > 2020-12-11 17:38 | Report Abuse

Why @kens88 so bitter ?

merck

996 posts

Posted by merck > 2020-12-11 17:52 | Report Abuse

What happen to KL2? Kossan Latex plant2. Anyone know?

Posted by Pgraduate123 > 2020-12-11 19:09 | Report Abuse

4.plus on Monday.. Con len firm Gostan

kens88

698 posts

Posted by kens88 > 2020-12-11 19:14 | Report Abuse

already said rm2. you stupid is it?

bsklshark

201 posts

Posted by bsklshark > 2020-12-11 19:56 | Report Abuse

Kossan factory also got positive case ma

Posted by influenza19 > 2020-12-11 20:12 | Report Abuse

Kossan at sungai putus. Relate to new cluster??

chhn461

279 posts

Posted by chhn461 > 2020-12-11 20:30 | Report Abuse

YTL is Top 10 stock in volume today, go figure.

merck

996 posts

Posted by merck > 2020-12-11 20:33 | Report Abuse

Kossan Sungai Putus? Covid?

Posted by PanjiAlam55 > 2020-12-11 20:38 | Report Abuse

Will drop more next week for sure hope it will drop till rm1 then many will buy back, after buy it will drop again till 0.10...that's will be great, then it will goes to N17 then shutdown.. that will more better. Hehehehe

Posted by PanjiAlam55 > 2020-12-11 20:49 | Report Abuse

It not possible price will go back to 2013:

Kossan Rubber Industries Bhd(Dec 3, RM3.70)Maintain buy at a fair value of RM3.80: We reaffirm our “buy” call on Kossan but place our fair value of RM3.80 per share under review following another strong run in its share price ( 14%) since trading ex-bonus on Nov 6, 2013 (when we raised our fair value by 21% to RM3.80 per share) and the announcement of its solid earnings for the nine months ended Sept 30 of financial year 2013 (9MFY13).

Just wait...

Posted by PanjiAlam55 > 2020-12-11 20:51 | Report Abuse

Will go to that prices very soon..

tan81

86 posts

Posted by tan81 > 2020-12-11 21:39 | Report Abuse

Tht area supermax factory as well.
Wait for confirmation.

shinrei

19 posts

Posted by shinrei > 2020-12-11 22:49 | Report Abuse

how come kossan so weak one?? hahahah!

gemfinder

6,880 posts

Posted by gemfinder > 2020-12-11 23:32 | Report Abuse

Insider said kisan got covid case

jeremylin

231 posts

Posted by jeremylin > 2020-12-12 01:50 | Report Abuse

Cant believe what Jp zhai wrote.....meaning to say others analyst (uob,pbb,myb,etc) make terrible mistake in their reports ?.....if want to uW also write reasonably la....takkan only you the one are correct, orher people no brain ka?

Foker

1,406 posts

Posted by Foker > 2020-12-12 02:48 | Report Abuse

Report Jeffrey Ng and YY Cheah to SC, both analyst at JP Morgan. Request for an investigation into these two individuals for market manipulating activities. What is the reason they start coverage on glove sector and immediately give an extremely low tp at 30% of consensus? If any hankypanky, their license should be revoked asap.

shinrei

19 posts

Posted by shinrei > 2020-12-12 06:29 | Report Abuse

i see no wonder drop. Jp Morgan.. lol

linheng

1,373 posts

Posted by linheng > 2020-12-12 07:17 | Report Abuse

Mad analyst. Top Glove at $3.80. Dividend at 16.5 cents per quarter is already 66 cents per year. The company got no asset ( not even land, buildings and cash reserve )

Legend

4,119 posts

Posted by Legend > 2020-12-12 07:46 | Report Abuse

JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over.

KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

Its analysts Jeffrey Ng and YY Cheah, in a note to clients today, said they expect glove prices to weaken in the second half of next year.

"Global testing trends have also plateaued, which ought to ease current supply tightness. JP Morgan’s proprietary fund flow analysis indicates the glove sector is a crowded trade, implying significant downside momentum. Near-term concerns on rising costs, plus long-term overcapacity risk, spell downside risks. Once Malaysia lifts the short selling ban, downward pressure could be amplified," they wrote.

Posted by Mr.Sm Invest123 > 2020-12-12 09:41 | Report Abuse

GG

gemfinder

6,880 posts

Posted by gemfinder > 2020-12-12 09:58 |

Post removed.Why?

jolow

652 posts

Posted by jolow > 2020-12-12 09:59 | Report Abuse

game over

Shines

2,824 posts

Posted by Shines > 2020-12-12 10:19 | Report Abuse

Mr.B says when people dont want I want, when people want then I dont want gave back to them.

stockraider

31,556 posts

Posted by stockraider > 2020-12-12 10:26 | Report Abuse

U R DEAD DUCK STAYING WITH GLOVES LOH....!!

THE SHARE PRICE IS GOING TO BE CUT BY HALF DUE TO FUTURE OUR CAPACITY & GLOVES GLUT COMING LOH...!!

READ JP MORGAN REPORT, U BETTER RUN B4 TOO LATE MAH,,,!!


Posted by Pgraduate123 > Dec 12, 2020 10:22 AM | Report Abuse

Stockraider, are you still in 1980's?

stockraider

31,556 posts

Posted by stockraider > 2020-12-12 10:29 | Report Abuse

Glove production capacity, they noted, is expected to grow 87% in the next three- to five years from this year’s, with 130 billion pieces per annum capacity to come from the big four glove makers of Top Glove, Hartalega, Kossan and Supermax Corp Bhd, and 20 billion pieces more from non-conventional players.

“The most worrying factor is oversupply, as we see not only significant capex plans from the big four producers but also from new players. While it is hard to measure the potential oversupply, we can take a leaf from the crude palm oil industry which saw a decade of oversupply post a supernormal cycle in the early 2000s,” they noted.

Additionally, glove makers' profitability is expected to be negatively affected by higher raw material prices and rising labour costs. "Pressure on foreign workers' treatment has and will continue to lift opex. Board members of certain glove producers have also asked for a raise in board fees. All these will add to higher opex and erode margins," they wrote.

Amid all this, they think the upside potential for glove stocks may be capped, with retail and foreign participation having reached all-time highs.

Malaysia’s government linked funds are the only hope to lift the sector, they wrote, yet they have also been trimming their exposure recently.

"The market cap of the top-four producers is RM170 billion, equal to 66% of local non-government-linked funds’ AUM (asset under management). Our proprietary analysis shows most funds have exposure in gloves and their cash holdings are low. To date, local mutual funds have invested 11% of AUM in gloves. Retail and foreign participation are at all-time highs. It is thus difficult to find incremental dollars to drive this sector higher," the note read.

Meanwhile, they noted that Top Glove and Hartalega's capital management decisions have not been optimal for creating value for shareholders due to the focus on accelerating capex via cash to support capacity growth.

Morpheus61

2,144 posts

Posted by Morpheus61 > 2020-12-12 10:41 | Report Abuse

Stokraider, honestly, which Invest Bank do you work for ?

stockraider

31,556 posts

Posted by stockraider > 2020-12-12 10:45 | Report Abuse

LISTEN DON BE SOHAI...HOLDING ON A FALLING KNIFE ON GLOVES STOCK LOH...!!

RUN 1ST....U CAN ALWAYS REVISIT GLOVES AT A MUCH LOWER PRICE AT LATER MAH...!!

RUN EARLY LOSSES WILL BE MUCH LESSER NOW MAH...!!

Morpheus61

2,144 posts

Posted by Morpheus61 > 2020-12-12 10:45 | Report Abuse

I have to hand it to JP Morgan for that absolutely IMPECCABLE TIMING of that TP. Monday to Thursday is the VWAP calculation for MacQuaire C69.

BRILLIANT JP MORGUE

Posted by EatCoconutCanWin > 2020-12-12 11:05 | Report Abuse

another briliant yy

jeremylin

231 posts

Posted by jeremylin > 2020-12-12 11:15 | Report Abuse

Is obvious stock raider work with JP TEAM

stockraider

31,556 posts

Posted by stockraider > 2020-12-12 11:17 | Report Abuse

U WAIT MAH....!!

AT LEAST 30% TO 50% DISCOUNT THEN DECIDE LOH...!!

Posted by CharlesT > Dec 12, 2020 11:14 AM | Report Abuse

Though i do not agree with the glove fanatic at all but i think somebody wanted to collect glove co shares cheap cheap by setting such low TPs

cbkia4896

936 posts

Posted by cbkia4896 > 2020-12-12 11:26 | Report Abuse

Later virus mutate. They give high TP... Fly again

jolow

652 posts

Posted by jolow > 2020-12-12 11:28 | Report Abuse

life is like a dick
sometimes it's up
sometimes it's down
but it won't be hard forever

Post a Comment
Market Buzz